Mesoblast Limited ( MEOBF) - Key Metrics
MEOBF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $0.03 | -$0.01 | -$0.01 | -$0.01 |
| 2026Q3 | $0.03 | -$0.01 | $0 | $0 |
| 2026Q2 | $0.02 | -$0.02 | -$0.01 | -$0.01 |
| 2026Q1 | $0.02 | -$0.02 | -$0.01 | -$0.01 |
| 2025Q4 | $0.01 | -$0.02 | -$0.01 | -$0.01 |
MEOBF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | -57.84 |
| 2026Q3 | 0% | -59.70 |
| 2026Q2 | 0% | -30.65 |
| 2026Q1 | 0% | -25.81 |
| 2025Q4 | 0% | -11.38 |
MEOBF
Price: $1.32
52 week price:
Earnings Per Share: -0.04 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.8 billion